Skip to main content
Monday, November 16, 2026Nov 16

Bond rating agencies praise Erlanger turnaround

Erlanger Hospital is seen from the new library's balcony Tuesday, Dec. 9, 2014, on the University of Tennessee at Chattanooga campus in Chattanooga, Tenn.
Erlanger Hospital is seen from the new library's balcony Tuesday, Dec. 9, 2014, on the University of Tennessee at Chattanooga campus in Chattanooga, Tenn.

After achieving record high profits just two years after the hospital suffered a string of record losses, Erlanger Health System picked up the endorsement of Wall Street analysts last week.

Moody’s Investors Service last week upgraded Erlanger’s rating outlook to “positive” and reaffirmed Erlanger’s Baa2 bond rating. Moody’s analysts said the improved assessment of Erlanger “reflects our expectations that with Erlanger’s leading and growing market presence, and performance strategies, improved operating cash flow generation will be sustained.”

The Moody’s report came out a day after Fitch Ratings-New York upgraded Erlanger’s bond rating from a BBB to BBB+, citing “leadership of a new CEO, increased volumes and a sharp improvement in operating results.”

In their analysis, Moody’s analysts wrote that Erlanger’s performance over the past two years was driven by a number of initiatives implemented since the arrival of Kevin Spiegel in April 2013. Erlanger revenues last year grew by 15 percent over the previous year.

Moody’s noted that Erlanger’s management “is projecting operating performance similar to 2015 and continues to focus on productivity, revenue cycle and supply chain initiatives.”